Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9383 | 1160 | 36.0 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
455 | 3 | HEMOGLOBIN//SICKLE CELL DISEASE//SICKLE CELL ANEMIA | 25359 |
1216 | 2 | PU1//ETS 1//GATA 1 | 9149 |
9383 | 1 | FETAL HEMOGLOBIN//HEMOGLOBINOPATHY THALASSEMIA UNIT//GAMMA GLOBIN | 1160 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FETAL HEMOGLOBIN | authKW | 1031387 | 9% | 38% | 104 |
2 | HEMOGLOBINOPATHY THALASSEMIA UNIT | address | 475110 | 2% | 95% | 19 |
3 | GAMMA GLOBIN | authKW | 430696 | 3% | 55% | 30 |
4 | BCL11A | authKW | 250040 | 2% | 50% | 19 |
5 | DEV PHARMACOL PHARMACOGENOM THER Y THALASS | address | 211819 | 1% | 62% | 13 |
6 | HBF INDUCTION | authKW | 193822 | 1% | 82% | 9 |
7 | ERYTHROID DIFFERENTIATION | authKW | 141904 | 3% | 14% | 39 |
8 | FETAL HAEMOGLOBIN | authKW | 134581 | 1% | 34% | 15 |
9 | HYDROXYUREA | authKW | 131979 | 6% | 7% | 74 |
10 | HBS1L MYB | authKW | 131610 | 0% | 100% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 41586 | 57% | 0% | 665 |
2 | Medicine, Research & Experimental | 918 | 11% | 0% | 133 |
3 | Genetics & Heredity | 331 | 8% | 0% | 97 |
4 | Biochemistry & Molecular Biology | 225 | 16% | 0% | 184 |
5 | Cell Biology | 149 | 8% | 0% | 91 |
6 | Biology | 95 | 3% | 0% | 38 |
7 | CYTOLOGY & HISTOLOGY | 78 | 0% | 0% | 5 |
8 | Medicine, General & Internal | 73 | 5% | 0% | 63 |
9 | Pediatrics | 60 | 4% | 0% | 41 |
10 | Oncology | 44 | 5% | 0% | 63 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEMOGLOBINOPATHY THALASSEMIA UNIT | 475110 | 2% | 95% | 19 |
2 | DEV PHARMACOL PHARMACOGENOM THER Y THALASS | 211819 | 1% | 62% | 13 |
3 | GENTECH THAL | 84229 | 0% | 80% | 4 |
4 | MOL GENOM THER EUT SECT | 82252 | 0% | 63% | 5 |
5 | MOL MED BRANCH | 64989 | 1% | 15% | 17 |
6 | CELL GENE THER Y GRP | 56094 | 1% | 24% | 9 |
7 | AL OMRAN SCI CHAIR HEMATOL DIS | 52644 | 0% | 100% | 2 |
8 | DEV GENE PHARMACOGEN THER Y THALASSAEMIA | 52644 | 0% | 100% | 2 |
9 | MED PEDIAT PHARMACOL EXPT THER EUT | 52644 | 0% | 100% | 2 |
10 | TOHOKU MED MEGABANK | 50613 | 0% | 38% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BLOOD CELLS MOLECULES AND DISEASES | 35570 | 4% | 3% | 49 |
2 | HEMOGLOBIN | 25785 | 4% | 2% | 47 |
3 | BLOOD | 21106 | 14% | 0% | 166 |
4 | EXPERIMENTAL HEMATOLOGY | 12910 | 5% | 1% | 53 |
5 | AMERICAN JOURNAL OF HEMATOLOGY | 8925 | 4% | 1% | 45 |
6 | BRITISH JOURNAL OF HAEMATOLOGY | 6509 | 5% | 0% | 58 |
7 | MINERVA BIOTECNOLOGICA | 3990 | 1% | 2% | 9 |
8 | TEXAS REPORTS ON BIOLOGY AND MEDICINE | 2937 | 0% | 3% | 4 |
9 | ACTA HAEMATOLOGICA | 2729 | 2% | 1% | 19 |
10 | HAEMATOLOGICA | 1831 | 1% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FETAL HEMOGLOBIN | 1031387 | 9% | 38% | 104 | Search FETAL+HEMOGLOBIN | Search FETAL+HEMOGLOBIN |
2 | GAMMA GLOBIN | 430696 | 3% | 55% | 30 | Search GAMMA+GLOBIN | Search GAMMA+GLOBIN |
3 | BCL11A | 250040 | 2% | 50% | 19 | Search BCL11A | Search BCL11A |
4 | HBF INDUCTION | 193822 | 1% | 82% | 9 | Search HBF+INDUCTION | Search HBF+INDUCTION |
5 | ERYTHROID DIFFERENTIATION | 141904 | 3% | 14% | 39 | Search ERYTHROID+DIFFERENTIATION | Search ERYTHROID+DIFFERENTIATION |
6 | FETAL HAEMOGLOBIN | 134581 | 1% | 34% | 15 | Search FETAL+HAEMOGLOBIN | Search FETAL+HAEMOGLOBIN |
7 | HYDROXYUREA | 131979 | 6% | 7% | 74 | Search HYDROXYUREA | Search HYDROXYUREA |
8 | HBS1L MYB | 131610 | 0% | 100% | 5 | Search HBS1L+MYB | Search HBS1L+MYB |
9 | KLF1 GENE | 109673 | 0% | 83% | 5 | Search KLF1+GENE | Search KLF1+GENE |
10 | FETAL HEMOGLOBIN HB F | 107476 | 1% | 58% | 7 | Search FETAL+HEMOGLOBIN+HB+F | Search FETAL+HEMOGLOBIN+HB+F |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MUSALLAM, KM , TAHER, AT , CAPPELLINI, MD , SANKARAN, VG , (2013) CLINICAL EXPERIENCE WITH FETAL HEMOGLOBIN INDUCTION THERAPY IN PATIENTS WITH BETA-THALASSEMIA.BLOOD. VOL. 121. ISSUE 12. P. 2199-2212 | 78 | 74% | 32 |
2 | MABAERA, R , WEST, RJ , CONINE, SJ , LOWREY, CH , ENGMAN, CA , BOYD, CD , MACARI, ER , (2008) A CELL STRESS SIGNALING MODEL OF FETAL HEMOGLOBIN INDUCTION: WHAT DOESN'T KILL RED BLOOD CELLS MAY MAKE THEM STRONGER.EXPERIMENTAL HEMATOLOGY. VOL. 36. ISSUE 9. P. 1057-1072 | 93 | 67% | 44 |
3 | BANAN, M , (2013) HYDROXYUREA TREATMENT IN BETA-THALASSEMIA PATIENTS: TO RESPOND OR NOT TO RESPOND?.ANNALS OF HEMATOLOGY. VOL. 92. ISSUE 3. P. 289-299 | 61 | 69% | 5 |
4 | TESTA, U , (2009) FETAL HEMOGLOBIN CHEMICAL INDUCERS FOR TREATMENT OF HEMOGLOBINOPATHIES.ANNALS OF HEMATOLOGY. VOL. 88. ISSUE 6. P. 505-528 | 94 | 47% | 23 |
5 | PERRINE, SP , PACE, BS , FALLER, DV , (2014) TARGETED FETAL HEMOGLOBIN INDUCTION FOR TREATMENT OF BETA HEMOGLOBINOPATHIES.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 28. ISSUE 2. P. 233-+ | 51 | 72% | 14 |
6 | THEIN, SL , (2012) THE EMERGING ROLE OF FETAL HEMOGLOBIN INDUCTION IN NON-TRANSFUSION-DEPENDENT THALASSEMIA.BLOOD REVIEWS. VOL. 26. ISSUE . P. S35-S39 | 47 | 84% | 11 |
7 | SRIPICHAI, O , FUCHAROEN, S , (2016) FETAL HEMOGLOBIN REGULATION IN BETA-THALASSEMIA: HETEROGENEITY, MODIFIERS AND THERAPEUTIC APPROACHES.EXPERT REVIEW OF HEMATOLOGY. VOL. 9. ISSUE 12. P. 1129 -1137 | 60 | 63% | 0 |
8 | DAI, Y , SANGERMAN, J , LUO, HY , FUCHAROEN, S , CHUI, DHK , FALLER, DV , PERRINE, SP , (2016) THERAPEUTIC FETAL-GLOBIN INDUCERS REDUCE TRANSCRIPTIONAL REPRESSION IN HEMOGLOBINOPATHY ERYTHROID PROGENITORS THROUGH DISTINCT MECHANISMS.BLOOD CELLS MOLECULES AND DISEASES. VOL. 56. ISSUE 1. P. 62 -69 | 46 | 81% | 0 |
9 | GAMBARI, R , FIBACH, E , (2007) MEDICINAL CHEMISTRY OF FETAL HEMOGLOBIN INDUCERS FOR TREATMENT OF BETA-THALASSEMIA.CURRENT MEDICINAL CHEMISTRY. VOL. 14. ISSUE 2. P. 199-212 | 68 | 59% | 17 |
10 | SANKARAN, VG , ORKIN, SH , (2013) THE SWITCH FROM FETAL TO ADULT HEMOGLOBIN.COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. VOL. 3. ISSUE 1. P. - | 48 | 56% | 40 |
Classes with closest relation at Level 1 |